Baltimore-Washington Financial Advisors’s Kazia Therapeutics KZIA Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-6	Closed	-$4K	–	313
2014 Q2	$4K	Buy	+6	New	+$4.61K	﹤0.01%	259
2014 Q1	–	Sell	-6	Closed	-$5K	–	263
2013 Q4	$5K	Buy	6 +5	+500%	+$4.81K	﹤0.01%	255
2013 Q3	$0	Buy	+1	New	+$781	﹤0.01%	215

Other funds holding KZIA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Baltimore-Washington Financial Advisors's KZIA Position: Q3 2014 in Review

Baltimore-Washington Financial Advisors sold out of Kazia Therapeutics (KZIA) in Q3 2014, closing a stake of 6 shares — an estimated $4K sold.

Baltimore-Washington Financial Advisors first reported a position in KZIA in Q3 2013 and held it in 3 quarters. The position peaked at $5K in Q4 2013. 5 funds tracked by Wall St. Rank hold KZIA as of Q3 2014.

Baltimore-Washington Financial Advisors reported no remaining Kazia Therapeutics position as of Q3 2014 after selling out during the quarter.
Baltimore-Washington Financial Advisors sold 6 Kazia Therapeutics shares in Q3 2014, an estimated $4K.
Baltimore-Washington Financial Advisors first reported a position in Kazia Therapeutics in Q3 2013 and held it in 3 quarters.
Baltimore-Washington Financial Advisors's Kazia Therapeutics position peaked at $5K in Q4 2013.
5 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2014.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q3 2014, filed 29 Oct 2014.